Page 198 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

188 ELECTROLYTE DISORDERS

ultrastructural, and histomorphometric investigations. 398. Murthy JN, Hicks JM, Soldin SJ. Evaluation of i-STAT
Lab Invest 1983;49:553–62. portable clinical analyzer in a neonatal and pediatric inten-
379. Meuten DJ, Segre GV, Capen CC, et al. Hypercalcemia in sive care unit. Clin Biochem 1997;30:385–9.
dogs with adenocarcinoma derived from apocrine glands 399. Naan EC, Kirpensteijn J, Kooistra HS, Peeters ME.
of the anal sac: biochemical and histomorphometric Results of thyroidectomy in 101 cats with hyperthyroid-
investigations. Lab Invest 1983;48:428–35. ism. Vet Surg 2006;35(3):287–93.
380. Meuten DJ. Hypercalcemia. Vet Clin North Am 400. Nachreiner RF, Refsal KR. The use of parathormone, ion-
1984;14:891–910. ized calcium and 25-hydroxyvitamin D assays to diagnose
381. Midkiff AM, Chew DJ, Randolph JF, et al. Idiopathic calcium disorders in dogs. In: Proc Am Coll Vet Intern
hypercalcemia in cats. J Vet Intern Med 2000;14:619–26. Med Forum, vol. 8. 1990.
382. Miki H, Maercklein PB, Fitzpatrick LA. Effect of magne- 401. Nagode LA, Chew DJ, Podell M. Benefits of calcitriol
sium on parathyroid cells: evidence for two sensing therapy and serum phosphorus control in dogs and cats
receptors or two intracellular pathways? Am J Physiol with chronic renal failure: both are essential to prevent
1997;272:E1–E6. or suppress toxic hyperparathyroidism. Vet Clin North
383. Miller D, Edmonds MW. Hypercalcemia due to hyper- Am Small Anim Pract 1996;26:1293–330.
parathyroidism treated with a somatostatin analogue. 402. Nagode LA, Chew DJ, Steinmeyer CL. The use of low
CMAJ 1991;145:227–8. doses of calcitriol in the treatment of renal secondary
384. Milner RJ, Farese J, Henry CJ, et al. Bisphosphonates and hyperparathyroidism. In: Proc 15th Waltham Symposium
cancer. J Vet Intern Med 2004;18:597–604. (Endocrinology). Columbus, Ohio; 1992.
385. Mischke R, Hanies R, Lange K, et al. The effect of the 403. Nagode LA, Chew DJ. Nephrocalcinosis caused by hyper-
albumin concentration on the relation between the con- parathyroidism in progression of renal failure: treatment
centration of ionized calcium and total calcium in with calcitriol. Semin Vet Med Surg (Small Anim)
the blood of dogs. Dtsch Tierarztl Wochenschr 1992;7:202–20.
1996;103:199–204. 404. Nagode LA, Chew DJ. The use of calcitriol in treatment of
386. Miwa N, Nitta K, Kimata N, et al. An evaluation of 1-84 renal disease of the dog and cat. In: Proc 1st Purina Int
PTH measurement in relation to bone alkaline phospha- Nutr Symp. 1991.
tase and bone Gla protein in hemodialysis patients. 405. Nagode LA, Steinmeyer CL, Chew DJ, et al. Hyper- and
Nephron Clin Pract 2003;94:c29–c32. normo-calcemic dogs with chronic renal failure: relations
387. Mizobuchi M, Towler D, Slatopolosky E. Vascular calcifi- of serum PTH and calcitriol to PTG Ca þþ set-point. In:
cation: the killer of patients with chronic kidney disease. Norman AW, Schaefer K, Grigoleit HG, et al., Vitamin
J Am Soc Nephrol 2009;20:1453–64. D. Molecular, cellular and clinical endocrinology. Berlin:
388. Mohn KL, Jacks TM, Schleim KD, Harvey CE, Miller B, Walter de Gruyter; 1988. p. 799–800.
Halley B, et al. Alendronate binds to tooth root surfaces 406. Negri AL, Alvarez Quiroga M, Bravo M, et al. Whole
and inhibits progression of feline tooth resorption: a pilot PTH and 1-84/84 PTH ratio for the non invasive deter-
proof-of-concept study. J Vet Dent 2009;26(2):74–81. mination of low bone turnover in renal osteodystrophy.
389. Mol JA, Kwant MM, Arnold IC, et al. Elucidation of Nefrologia 2003;23:327–32.
the sequence of canine (pro)-calcitonin: a molecular 407. Nemeth EF, Heaton WH, Miller M, et al. Pharmacody-
biological and protein chemical approach. Regul Pept namics of the type II calcimimetic compound Cinacalcet
1991;35:189–95. HCl. J Pharmacol Exp Ther 2004;308:627–35.
390. Moore FM, Kudisch M, Richter K, et al. Hypercalcemia 408. Nemzek JA, Kruger JM, Walshaw R, et al. Acute onset of
associated with rodenticide poisoning in three cats. hypokalemia and muscular weakness in four hyperthyroid
J Am Vet Med Assoc 1988;193:1099–100. cats. J Am Vet Med Assoc 1994;205:65–8.
391. Morita T, Awakura T, Shimada A, et al. Vitamin D toxico- 409. Neuman NB. Acute pancreatic hemorrhage associated
sis in cats: natural outbreak and experimental study. J Vet with iatrogenic hypercalcemia in a dog. J Am Vet Med
Med Sci 1995;57:831–7. Assoc 1975;166:381–3.
392. Morris JG. Vitamin D synthesis by kittens. Vet Clin Nutr 410. Neves M, Gano L, Pereira N, et al. Synthesis, characteri-
1996;3:88–92. zation and biodistribution of bisphosphonates Sm-153
393. Morris SA, Bilezikian JP. Signal transduction in bone complexes: correlation with molecular modeling interac-
physiology: messenger systems for parathyroid hormone. tion studies. Nucl Med Biol 2002;29:329–38.
In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles 411. Neville-Webbe H, Coleman RE. The use of zoledronic
of bone biology. New York: Academic Press; 1996. acid in the management of metastatic bone disease and
p. 1203–1215. hypercalcaemia. Palliat Med 2003;17:539–53.
394. Morrow CMK, Valli VE, Volmer PA, et al. Canine renal 412. Neville-Webbe HL, Holen I, Coleman RE. The anti-
pathology associated with grape or raisin ingestion: 10 tumour activity of bisphosphonates. Cancer Treat Rev
cases. J Vet Diagn Invest 2005;17:223–31. 2002;28:305–19.
395. Mosdell KW, Visconti JA. Emerging indications for 413. Nguyen-Yamamoto L, Rousseau L, Brossard JH, et al.
octreotide therapy, part 1. Am J Hosp Pharm Origin of parathyroid hormone (PTH) fragments detected
1994;51:1184–92. by intact-PTH assays. Eur J Endocrinol 2002;147:123–31.
396. Moseley JM, Kubota M, Diefenbach-Jagger H, et al. Para- 414. Nguyen-Yamamoto L, Rousseau L, Brossard JH, et al.
thyroid hormone-related protein purified from a human Synthetic carboxyl-terminal fragments of parathyroid hor-
lung cancer cell line. Proc Natl Acad Sci USA mone (PTH) decrease ionized calcium concentration in
1987;84:5048–52. rats by acting on a receptor different from the PTH/
397. Mundy GR, Oyajobi B. Other local and ectopic hormone PTH-related peptide receptor. Endocrinology
syndromes associated with hypercalcemia. In: Bilezikian JP, 2001;142:1386–92.
MarcusR,LevineMA,editors.Theparathyroids.SanDiego: 415. Niemann JT, Cairns CB. Hyperkalemia and ionized hypo-
Academic Press; 2001. p. 691–706. calcemia during cardiac arrest and resuscitation: possible